|
Volumn 43, Issue 4, 2011, Pages 1039-1041
|
Multimodal therapy with combined plasmapheresis, photoapheresis, and intravenous immunoglobulin for acute antibody-mediated renal transplant rejection: A 2-year follow-up
|
Author keywords
[No Author keywords available]
|
Indexed keywords
IMMUNOGLOBULIN;
ADULT;
ANTIBODY MEDIATED ACUTE REJECTION;
CASE REPORT;
CONFERENCE PAPER;
DRUG MEGADOSE;
EXTRACORPOREAL PHOTOPHERESIS;
FEMALE;
FOLLOW UP;
GRAFT SURVIVAL;
HUMAN;
KIDNEY GRAFT REJECTION;
MALE;
PLASMAPHERESIS;
PRIORITY JOURNAL;
PUVA;
RENAL GRAFT DYSFUNCTION;
SAFETY;
T LYMPHOCYTE;
ACUTE DISEASE;
ADULT;
BIOLOGICAL MARKERS;
COMBINED MODALITY THERAPY;
CREATININE;
FEMALE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMANS;
IMMUNOGLOBULINS, INTRAVENOUS;
IMMUNOSUPPRESSIVE AGENTS;
ISOANTIBODIES;
KIDNEY TRANSPLANTATION;
MALE;
MIDDLE AGED;
PHOTOPHERESIS;
PLASMAPHERESIS;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 79957616417
PISSN: 00411345
EISSN: 18732623
Source Type: Journal
DOI: 10.1016/j.transproceed.2011.03.023 Document Type: Conference Paper |
Times cited : (6)
|
References (4)
|